These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children. Qadri F, Wennerâs C, Ahmed F, Asaduzzaman M, Saha D, Albert MJ, Sack RB, Svennerholm A. Vaccine; 2000 Jun 01; 18(24):2704-12. PubMed ID: 10781858 [Abstract] [Full Text] [Related]
6. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group. Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M, El Mohamady H, Abu-Elyazeed R, Naficy A, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD. J Infect Dis; 1999 Jan 01; 179(1):107-14. PubMed ID: 9841829 [Abstract] [Full Text] [Related]
7. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Jertborn M, Ahrén C, Svennerholm AM. Clin Diagn Lab Immunol; 2001 Mar 01; 8(2):424-8. PubMed ID: 11238232 [Abstract] [Full Text] [Related]
9. Safety, immunogenicity, and lot stability of the whole cell/recombinant B subunit (WC/rCTB) cholera vaccine in Peruvian adults and children. Taylor DN, Cárdenas V, Perez J, Puga R, Svennerholm AM. Am J Trop Med Hyg; 1999 Dec 01; 61(6):869-73. PubMed ID: 10674661 [Abstract] [Full Text] [Related]
11. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae. Tobias J, Lebens M, Bölin I, Wiklund G, Svennerholm AM. Vaccine; 2008 Feb 06; 26(6):743-52. PubMed ID: 18191006 [Abstract] [Full Text] [Related]
13. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Ahrén C, Wennerås C, Holmgren J, Svennerholm AM. Vaccine; 1993 Feb 06; 11(9):929-34. PubMed ID: 8212839 [Abstract] [Full Text] [Related]
14. Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children. Qadri F, Ahmed F, Ahmed T, Svennerholm AM. Infect Immun; 2006 Aug 06; 74(8):4512-8. PubMed ID: 16861637 [Abstract] [Full Text] [Related]
15. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants. Savarino SJ, Hall ER, Bassily S, Wierzba TF, Youssef FG, Peruski LF, Abu-Elyazeed R, Rao M, Francis WM, El Mohamady H, Safwat M, Naficy AB, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD, Pride Study Group. Pediatr Infect Dis J; 2002 Apr 06; 21(4):322-30. PubMed ID: 12075764 [Abstract] [Full Text] [Related]
18. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR. Infect Immun; 1999 Dec 06; 67(12):6249-56. PubMed ID: 10569734 [Abstract] [Full Text] [Related]
19. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country. Akhtar M, Qadri F, Bhuiyan TR, Akter S, Rafique TA, Khan A, Islam LN, Saha A, Svennerholm AM, Lundgren A. Vaccine; 2017 Jan 05; 35(2):321-328. PubMed ID: 27916412 [Abstract] [Full Text] [Related]